Home » Authors » James Etheridge

James Etheridge

Articles

ARTICLES

NicOx Grants AstraZeneca Exclusive License For Japan

Oct. 1, 2002

By James Etheridge

Neuro3d Raises EUR20M Privately To Fund Work In CNS Disorders

Sep. 25, 2002

By James Etheridge

Genset Shareholders Accept Bid From Serono; Integration Begins

Sep. 25, 2002

By James Etheridge

Genset Shareholders Accept Bid From Serono; Integration Begins

Sep. 25, 2002

By James Etheridge

Neuro3d Raises EUR20M Privately To Fund Work In CNS Disorders

Sep. 25, 2002

By James Etheridge

Euroscreen Granted U.S. Patent Covering Human CCR5 Receptor

Sep. 18, 2002

By James Etheridge

French Researchers Discover Genetic Origin For Colon Cancer

Sep. 18, 2002

By James Etheridge

French Researchers Discover Genetic Origin For Colon Cancer

Sep. 18, 2002

By James Etheridge

Euroscreen Granted U.S. Patent Covering Human CCR5 Receptor

Sep. 18, 2002

By James Etheridge

With New Premises, Tropos Launches €15M Funding Round

Sep. 11, 2002

By James Etheridge

View All Articles by James Etheridge

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...